Answers are grounded in this paper and cite their sources.
Herein, a self-adjuvanting fluorinated MUC1-based nanoliposomal antitumor vaccine was constructed for the first time. Both the tumor-associated antigen and the mode of its presentation affect the immune response for antitumor vaccines.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: